Intravenous methylprednisolone pulse therapy and the risk of ... | 私立大學五星教授網

pulse therapy ）以搶救病患急速的器官功能惡化。病況控治後，逐漸減少 劑量至最低。若需長期服用，則儘可能把一日總劑量在早晨一次服用完畢， 更安全作法是〞間日給予 ...

由 K Masuyama 著作 · 1993 · 被引用 4 次 — In conclusion MTP pulse therapy as the initial treatment may be beneficial in treating patients with Wegener's granulomatosis. Publication types. Case Reports ...

由 EC Wong 著作 · 2014 · 被引用 1 次 — A typical pulse regimen ranges from 500 to 1000 mg IV daily for 2–4 consecutive days., It has been suggested that methylprednisolone may cause an acute increase ...

由 K Masuyama 著作 · 1993 · 被引用 4 次 — In conclusion MTP pulse therapy as the initial treatment may be beneficial in treating patients with Wegener's granulomatosis.

由 T Moromizato 著作 · 2023 · 被引用 2 次 — The results of our study suggest that intravenous methylprednisolone showed dose–response efficiencies, and pulse therapy may benefit critically ...

由 M Edalatifard 著作 · 2020 · 被引用 410 次 — Methylprednisolone is a glucocorticoid medication used to suppress the autoimmune and inflammatory responses in rheumatic diseases [10].

由 CH Liu 著作 · 2007 · 被引用 2 次 — Conclusion: Intravenous MP pulse therapy is the potent anti-inflammatory and immunosuppressive therapy for inflammatory autoimmune disease. From our finding, MP ...

由 H Okano 著作 · 2022 · 被引用 3 次 — Steroid pulse therapy could improve 28-day mortality in critically ill COVID-19 pneumonia patients. However, this study included a small sample ...

由 RJ van Geest 著作 · 2008 · 被引用 136 次 — AbstractObjective. To assess whether methylprednisolone (MP) pulse therapy is efficacious in the treatment of moderately severe Graves' orbitopathy (GO).